BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18662588)

  • 1. Mutant p27(Kip1) and its potential effect as hepatocellular gene therapy.
    Lu M; Fei M; Cheng C; Wang Y; He S; Zhao Y; Gao S; Ke Q; Li P; Cui X; Shen A
    Arch Med Res; 2008 Aug; 39(6):573-81. PubMed ID: 18662588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of phosphorylation sites Ser10 and Thr187 of p27Kip1 abolish cytoplasmic redistribution but do not abrogate G0/1 phase arrest in the HepG2 cell line.
    Guan X; Chen L; Wang J; Geng H; Chu X; Zhang Q; Du L; De W
    Biochem Biophys Res Commun; 2006 Sep; 347(3):601-7. PubMed ID: 16842750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of the pulmonary metastatic tumors by systemic delivery of the p27 kip1 gene using lyophilized lipid-polycation-DNA complexes.
    Sun X; Zhang HW; Zhang ZR
    J Gene Med; 2009 Jun; 11(6):535-44. PubMed ID: 19326369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Overexpression of p27(KIP1) induced by Bak gene leads to the arrest in G(1) phase of HCC-9204 cell line].
    Li J; Wang W; Yu X; Yang X; Hou Y
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():27-9. PubMed ID: 11509132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
    Liu TZ; Chen CY; Yiin SJ; Chen CH; Cheng JT; Shih MK; Wang YS; Chern CL
    Food Chem Toxicol; 2006 Feb; 44(2):227-35. PubMed ID: 16112786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated p27Kip1 on Thr157 is an important prognosis in human hepatocellular carcinoma in vivo and in vitro.
    He S; Lu M; Xue W; Wang Y; Zhao Y; Gao S; Ke Q; Liu Y; Li P; Cui X; Cheng C; Shen A
    Med Oncol; 2011 Mar; 28(1):94-104. PubMed ID: 20108172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
    Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I
    Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin dependent kinase inhibitor p27(Kip1) is upregulated by hypoxia via an ARNT dependent pathway.
    Wang G; Reisdorph R; Clark RE; Miskimins R; Lindahl R; Miskimins WK
    J Cell Biochem; 2003 Oct; 90(3):548-60. PubMed ID: 14523989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.
    Boehm M; Yoshimoto T; Crook MF; Nallamshetty S; True A; Nabel GJ; Nabel EG
    EMBO J; 2002 Jul; 21(13):3390-401. PubMed ID: 12093740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression, localization and interrelationship of P27kip1 and cyclin D3 in non-Hodgkin's lymphoma].
    Zhang DM; Lu JX; Shen AG; Chen L; He S; Shao XY; Liu HO; Cheng C
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):723-7. PubMed ID: 16620575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal requirements for the nuclear localization of p27(Kip1), a cyclin-dependent kinase inhibitor.
    Zeng Y; Hirano K; Hirano M; Nishimura J; Kanaide H
    Biochem Biophys Res Commun; 2000 Jul; 274(1):37-42. PubMed ID: 10903892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.
    Hsieh YH; Su IJ; Wang HC; Tsai JH; Huang YJ; Chang WW; Lai MD; Lei HY; Huang W
    Mol Cancer Res; 2007 Oct; 5(10):1063-72. PubMed ID: 17951406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.
    Chu IM; Hengst L; Slingerland JM
    Nat Rev Cancer; 2008 Apr; 8(4):253-67. PubMed ID: 18354415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth.
    Shiraso S; Katayose Y; Yamamoto K; Mizuma M; Yabuuchi S; Oda A; Rikiyama T; Onogawa T; Yoshida H; Hayashi H; Ohtsuka H; Motoi F; Egawa S; Kato J; Unno M
    Anticancer Res; 2009 Jun; 29(6):2015-24. PubMed ID: 19528460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Up-regulation of p27(kip1) by miR-221/222 antisense oligonucleotides enhances the radiosensitivity of U251 glioblastoma].
    Zhang C; Wang G; Kang C; Du Y; Pu P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Dec; 26(6):634-8. PubMed ID: 19953484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
    Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S
    Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 induction of cellular migration requires p27(KIP1).
    Li Z; Jiao X; Wang C; Ju X; Lu Y; Yuan L; Lisanti MP; Katiyar S; Pestell RG
    Cancer Res; 2006 Oct; 66(20):9986-94. PubMed ID: 17047061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the cell cycle inhibitor Kip1/p27 in childhood leukemia.
    Markaki EA; Stiakaki E; Zafiropoulos A; Arvanitis DA; Katzilakis N; Dimitriou H; Spandidos DA; Kalmanti M
    Pediatr Blood Cancer; 2006 Jul; 47(1):14-21. PubMed ID: 16526056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 regulates p27(Kip1) stability in B cells.
    Bustany S; Tchakarska G; Sola B
    Cell Signal; 2011 Jan; 23(1):171-9. PubMed ID: 20837141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
    Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY
    J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.